Cargando…

ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of thyroid nodules and cancer

Most patients with thyroid nodules and thyroid cancer (TC) referred for diagnostic work-up and treatment are not considered at higher risk of infection from SARS-CoV-2 compared to the general population. On the other hand, healthcare resources should be spared to the maximum extent possible during a...

Descripción completa

Detalles Bibliográficos
Autores principales: Vrachimis, Alexis, Iakovou, Ioannis, Giannoula, Evanthia, Giovanella, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938009/
https://www.ncbi.nlm.nih.gov/pubmed/32438345
http://dx.doi.org/10.1530/EJE-20-0269
_version_ 1783661512842280960
author Vrachimis, Alexis
Iakovou, Ioannis
Giannoula, Evanthia
Giovanella, Luca
author_facet Vrachimis, Alexis
Iakovou, Ioannis
Giannoula, Evanthia
Giovanella, Luca
author_sort Vrachimis, Alexis
collection PubMed
description Most patients with thyroid nodules and thyroid cancer (TC) referred for diagnostic work-up and treatment are not considered at higher risk of infection from SARS-CoV-2 compared to the general population. On the other hand, healthcare resources should be spared to the maximum extent possible during a pandemic. Indeed, while thyroid nodules are very common, only a small percentage are cancerous and, in turn, most thyroid cancers are indolent in nature. Accordingly, diagnostic work-up of thyroid nodules, thyroid surgery for either benign or malignant thyroid nodules and radioiodine treatment for differentiated thyroid cancers may be safely postponed during SARS-CoV-2 pandemic. Appropriate patient counselling, however, is mandatory and red flags should be carefully identified prompting immediate evaluation and treatment as appropriate. For these selected cases diagnostic work-up (e.g. ultrasound, scintigraphy, fine-needle aspiration), surgery and radioiodine therapy may proceed despite the threat of SARS-CoV-2 infection and COVID-19, after an individual risk-benefit analysis.
format Online
Article
Text
id pubmed-7938009
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-79380092021-03-11 ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of thyroid nodules and cancer Vrachimis, Alexis Iakovou, Ioannis Giannoula, Evanthia Giovanella, Luca Eur J Endocrinol Clinical Practice Guidance Most patients with thyroid nodules and thyroid cancer (TC) referred for diagnostic work-up and treatment are not considered at higher risk of infection from SARS-CoV-2 compared to the general population. On the other hand, healthcare resources should be spared to the maximum extent possible during a pandemic. Indeed, while thyroid nodules are very common, only a small percentage are cancerous and, in turn, most thyroid cancers are indolent in nature. Accordingly, diagnostic work-up of thyroid nodules, thyroid surgery for either benign or malignant thyroid nodules and radioiodine treatment for differentiated thyroid cancers may be safely postponed during SARS-CoV-2 pandemic. Appropriate patient counselling, however, is mandatory and red flags should be carefully identified prompting immediate evaluation and treatment as appropriate. For these selected cases diagnostic work-up (e.g. ultrasound, scintigraphy, fine-needle aspiration), surgery and radioiodine therapy may proceed despite the threat of SARS-CoV-2 infection and COVID-19, after an individual risk-benefit analysis. Oxford University Press 2020-07-01 /pmc/articles/PMC7938009/ /pubmed/32438345 http://dx.doi.org/10.1530/EJE-20-0269 Text en © 2020 The authors https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by/4.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Clinical Practice Guidance
Vrachimis, Alexis
Iakovou, Ioannis
Giannoula, Evanthia
Giovanella, Luca
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of thyroid nodules and cancer
title ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of thyroid nodules and cancer
title_full ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of thyroid nodules and cancer
title_fullStr ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of thyroid nodules and cancer
title_full_unstemmed ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of thyroid nodules and cancer
title_short ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of thyroid nodules and cancer
title_sort endocrinology in the time of covid-19: management of thyroid nodules and cancer
topic Clinical Practice Guidance
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938009/
https://www.ncbi.nlm.nih.gov/pubmed/32438345
http://dx.doi.org/10.1530/EJE-20-0269
work_keys_str_mv AT vrachimisalexis endocrinologyinthetimeofcovid19managementofthyroidnodulesandcancer
AT iakovouioannis endocrinologyinthetimeofcovid19managementofthyroidnodulesandcancer
AT giannoulaevanthia endocrinologyinthetimeofcovid19managementofthyroidnodulesandcancer
AT giovanellaluca endocrinologyinthetimeofcovid19managementofthyroidnodulesandcancer